A diagnostic conundrum: Heterophilic antibody interference in an adrenocorticotropic hormone immunoassay not detectable using a proprietary heterophile blocking reagent

Annals of Clinical Biochemistry

Volumn 50, Issue 5, 2013, Pages 433-437

  Grasko, Jonathan ^a   Willliams, Robin ^b   Beilin, Jonathan ^c   Glendenning, Paul ^c,d,e   Fermoyle, Soraya ^c   Vasikaran, Samuel ^c,d  

^a QE2 Medical Center   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Adrenocorticotropic hormone; Heterophile antibodies; Immunoassay

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; HETEROPHILE ANTIBODY; HYDROCORTISONE;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ADVERSE OUTCOME; ALDOSTERONE BLOOD LEVEL; ARTICLE; AUTOMATION; BONE DENSITY; CASE REPORT; CHEMOLUMINESCENCE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DUAL ENERGY X RAY ABSORPTIOMETRY; ECTOPIC CORTICOTROPIN PRODUCTION; ENZYME IMMUNOASSAY; FEMALE; HEALTH CARE COST; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERTENSION; INFERIOR PETROSAL SINUS; LABORATORY TEST; LIMIT OF DETECTION; MOON FACE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN BRUISING; WEIGHT GAIN;

EID: 84890207556     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213487514     Document Type: Article

References (12)

1. Berson SA, Yalow RS, Bauman A, et al. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest 1956; 35: 170-190.
2. Bolstad N, Warren DJ, Bjerner J, et al. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera. Clin Chem Lab Med 2011; 49: 2001-2006.
3. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999; 45: 942-956.
4. Preissner CM, O'Kane DJ, Singh RJ, et al. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003; 88: 3069-3074.
5. Saleem M, Lewis JG, Florkowski CM, et al. A patient with pseudo-Addison's disease and falsely elevated thyroxine due to interference in serum cortisol and free thyroxine immunoassays by two different mechanisms. Ann Clin Biochem 2009; 46: 172-175.
6. Tate J and Ward G. Interferences in immunoassay. Clin Biochem Rev 2004; 25: 105-120.
7. Haning R, Tait SA and Tait JF. In vitro effects of ACTH, angiotensins, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells. Endocrinology 1970; 87: 1147-1167
8. Sexually transmitted infections. Current epidemiological perspective on world-wide infections with aspects on transmission, molecular biology, epidemiological control and prevention. Berzelius Symposium XVII, Swedish Society of Medicine, 22-24 May 1989, Orsundsbro (Uppsala), Sweden. Proceedings. Scand J Infect Dis Suppl 1990; 69: 1-211.
9. Preissner CM, Dodge LA, O'Kane DJ, et al. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem 2005; 51: 208-210.
10. John M, Lila AR, Bandgar T, et al. Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome. Pituitary 2010; 13: 48-53.
11. Klose M, Kofoed-Enevoldsen A and Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and -independent Cushing's syndrome. Scand J Clin Lab Invest 2002; 62: 33-37.
12. Newell-Price J, Bertagna X, Grossman AB, et al. Cushing's syndrome. Lancet 2006; 367: 1605-1617.